Average Co-Inventor Count = 4.67
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-La Roche Inc. (50 from 4,948 patents)
2. Siena Biotech S.p.a. (6 from 11 patents)
3. F. Hoffmann-La Roche Ag (168 patents)
50 patents:
1. 9242943 - 1,4 oxazines as BACE1 and/or BACE2 inhibitors
2. 9115098 - 1,3-oxazines as BACE1 and/or BACE2 inhibitors
3. 9079919 - Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as BACE1 and/or BACE2 inhibitors
4. 8877744 - 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
5. 8815881 - 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
6. 8785436 - 1,3-oxazines as BACE 1 and/or BACE2 inhibitors
7. 8754075 - 1,3-oxazines as BACE1 and/or BACE2 inhibitors
8. 8748418 - 1,4-oxazepines as BACE1 and/or BACE2 inhibitors
9. 8673894 - 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
10. 8399459 - 1,4 oxazines as BACE1 and/or BACE2 inhibitors
11. 8389513 - 2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides
12. 8227505 - Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
13. 8188079 - 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
14. 7989449 - 4,5-dihydro-oxazol-2-yl amine derivatives
15. 7544679 - 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives